THE LEUKAEMIA FOUNDATION - National Research ProgramGrant Recipients - 2010 |
 |
Philip Desbrow Senior Research Fellowship
|
funds per annum | |
Dr Carl Walkley |
Cell division, blood stem cells and proliferative disease (MDS) | more | $200,000 |
PhD Scholarships
|
||
Ms S. Charmsaz |
EphA proteins may be therapy targets in leukaemia (LEUKAEMIA) | more | $40,000 |
Ms U. Sansom -Daly |
Where to after treatment? A new way to support young people with cancer and their parents (PSYCHOSOCIAL) | more | $40,000 |
Ms L. Schafranek |
Eradication of leukaemic stem cells using therapy combinations in CML (CML) | more | $40,000 |
Ms L.Varghese |
Understanding the molecular mechanisms that regulate blood stem cell activity (LEUKAEMIA/LYMPHOMA) | more | $40,000 |
Mr D. Watkins |
Defining the unique characteristics of CP-CML patients that respond poorly to imatinib (CML) | more | $40,000 |
Mr J. Wong |
Targeting signaling in acute lymphoblastic leukaemia (ALL) | more | $40,000 |
PhD (Clinical) Scholarship
|
||
Dr A. Johnston (PwC Fellowship) |
Identification of genetic changes in aggressive B-cell lymphomas and impact on tumour growth (LYMPHOMA) | more | $55,000 |
Dr C. Wallington-Beddoe |
New therapies for acute lymphoblastic leukaemia (ALL)| more | $55,000 |
Post-Doctoral Fellowships |
||
Ms T. Clinton-McHarg |
Psychosocial outcomes in blood cancer: role of treatment centre structures and processes (PSYCHOSOCIAL) | $94,064 |
Dr M. van Leeuwen |
The risk of haematopoietic cancer in people hospitalised with an processes autoimmune disease (EPIDEMIOLOGY) | more | $91,000 |
Dr M. McKenzie |
Understanding the molecular basis of lymphoma cell death (LYMPHOMA) | more | $99,000 |
Research Grants-in-Aid |
||
Dr G. Best and Assoc Prof S. Mulligan |
A novel agent targeting the HSP90 protein in CLL (CLL) | more | $100,000 |
Dr H. Cullup |
Methods to prevent GVHD after transplantation (GVHD) | more | $100,000 |
Assoc Prof P. Ekert |
Blocking Hox genes to treat leukaemia (LEUKAEMIA) | more | $98,000 |
Dr S. Fuller et al |
Study of genes that cause CLL (CLL) | more | $100,000 |
Assoc Prof D.Gill and Dr N. McMillan |
Novel growth factors in CLL (CLL) | more | $100,000 |
Dr C. Hawkins |
Definition of the mechanism by which capase-2 suppresses lymphomagenesis (LYMPHOMA) | more | $56,256 |
Dr K. Mason et al |
Promoting cell death to improve treatment of CLL (CLL) | more | $100,000 |
Dr P. Neeson and Assoc Prof D. Ritchie |
A new CLL model that aids better understanding of the disease and how to treat it effectively (CLL) | more | $98,000 |
Dr J. Pimanda |
Do leukaemic cells adopt blood stem cell properties to induce leukaemia? (LEUKAEMIA) | more | $98,000 |
Dr L. Purton and Dr M. Askmyr |
Helping blood cell numbers recover after transplantation or chemotherapy | more | $98,000 |
Assoc Prof D. Ritchie and Dr P. Neeson |
Using the immune system against CLL (CLL) | more | $50,000 |
Dr S. Ting and Dr S. Russell |
Understanding how blood and leukaemia cells function (LEUKAEMIA) | more | $50,000 |
Dr S. Vuckovic and Dr L. Catley |
Regulatory role of VEGF on human dendritic cells in multiple myeloma – infiltrated bone marrow (MM) | more | $100,000 |
Honours Scholarship |
||
Mr T.Colgan (di Giacomo Scholarship) |
Developing a method to isolate notch-induced cancer cells (LEUKAEMIA) | more | $10,000 |
New Investigators Grant |
||
Ms Kaija Strautin |
Measurement of blood markers to determine cell therapy treatment for graft versus host disease (GVHD) | more | $5,000 |
Cancer Australia PdCCRS Funding Partnership |
||
Dr John Seymour |
Randomised phase III trial to assess response adapted therapy using PET in newly diagnosed advanced Hodgkin lymphoma (HL) | more | $36,000 |
